SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS (STNF-R) AND HIV-INFECTION - CORRELATION TO CD8+ LYMPHOCYTES

被引:28
作者
KALINKOVICH, A
LIVSHITS, G
ENGELMANN, H
HARPAZ, N
BURSTEIN, R
KAMINSKY, M
WALLACH, D
BENTWICH, Z
机构
[1] HEBREW UNIV JERUSALEM,KAPLAN HOSP,SCH MED,R BEN ARI INST CLIN IMMUNOL,IL-76100 REHOVOT,ISRAEL
[2] TEL AVIV UNIV,SACKLER FAC MED,DEPT ANAT & ANTHROPOL,IL-69978 TEL AVIV,ISRAEL
[3] WEIZMANN INST SCI,DEPT MEMBRANE RES & BIOPHYS,IL-76100 REHOVOT,ISRAEL
关键词
SOLUBLE TUMOR NECROSIS FACTOR RECEPTORS; HIV INFECTION; CD8+ LYMPHOCYTES;
D O I
10.1111/j.1365-2249.1993.tb08184.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objective of this study was to determine sTNF-R, type I (p55) and type II (p75) in sera of HIV-infected male homosexuals and correlate them to T lymphocyte subpopulations and course of HIV infection. Serum samples were obtained from 39 HIV-1+ asymptomatic male homosexuals, 10 symptomatic (ARC and AIDS) male homosexuals and 44 HIV- non-homosexual healthy controls. sTNF-R levels were determined by ELISA with specific MoAbs and polyclonal antibodies to the sTNF-R proteins. sTNF-RI and II levels were significantly elevated in 72% and 74% respectively of HIV+ asymptomatic male homosexuals and in all of the symptomatic male homosexuals. In sequential studies a highly significant positive correlation was found between sTNF-RI and sTNF-RII (r=0.8, P<0.001) and between both sTNF-R and CD8+ lymphocyte counts (r=0.6 and 0.92, respectively, P<0.01-0.001) during the asymptomatic stage of the infection. All these correlations were lost, however, during the symptomatic phase of the disease. These results suggest that: (i) HIV infection is associated with elevation of sTNF-R serum levels; (ii) sTNF-R levels are strongly correlated to CD8+ lymphocytes during the asymptomatic stage of HIV infection.
引用
收藏
页码:350 / 355
页数:6
相关论文
共 58 条
[51]  
TOMKINSON BE, 1989, J IMMUNOL, V142, P2230
[52]  
VANDERPOLL T, 1992, EUR CYTOKINE NETW, V3, P214
[53]   SUBSET MARKERS OF CD8(+) CELLS AND THEIR RELATION TO ENHANCED CYTOTOXIC T-CELL ACTIVITY DURING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
VANHAM, G ;
KESTENS, L ;
PENNE, G ;
GOILAV, C ;
GIGASE, P ;
COLEBUNDERS, R ;
VANDENBRUAENE, M ;
GOEMAN, J ;
VANDERGROEN, G ;
CEUPPENS, JL .
JOURNAL OF CLINICAL IMMUNOLOGY, 1991, 11 (06) :345-356
[54]   TUMOR-NECROSIS-FACTOR SOLUBLE RECEPTORS CIRCULATE DURING EXPERIMENTAL AND CLINICAL INFLAMMATION AND CAN PROTECT AGAINST EXCESSIVE TUMOR-NECROSIS-FACTOR-ALPHA INVITRO AND INVIVO [J].
VANZEE, KJ ;
KOHNO, T ;
FISCHER, E ;
ROCK, CS ;
MOLDAWER, LL ;
LOWRY, SF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) :4845-4849
[55]   INTERFERON-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA IN SERUM OF PATIENTS IN VARIOUS STAGES OF HIV-1 INFECTION [J].
VONSYDOW, M ;
SONNERBORG, A ;
GAINES, H ;
STRANNEGARD, O .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (04) :375-380
[56]  
WATRET KC, 1993, CLIN EXP IMMUNOL, V92, P93
[57]  
YAGI MJ, 1992, CLIN IMMUNOL IMMUNOP, V63, P1216
[58]   QUANTITATION OF BETA-2-MICROGLOBULIN AND OTHER IMMUNE CHARACTERISTICS IN A PROSPECTIVE-STUDY OF MEN AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME [J].
ZOLLAPAZNER, S ;
WILLIAM, D ;
ELSADR, W ;
MARMOR, M ;
STAHL, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (22) :2951-2955